FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/09/2025
Back to search
Official data from USPTO
OMERO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
OMERO
ST13
US500000079315257Class
9, 35, 42, 45
Filing
79315257
Registration
7497630
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
05/10/2025
Trademark type
Word
Nice classes
9, 35, 42, 45
Filing date
03/09/2021
Registration date
09/10/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/10/2024
Last transaction
05/10/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
Seattle, WA
Examiner
MONINGHOFF, KIM
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Glencoe Software Inc.
Representatives
STACEY J. WATSON, ESQ. MARKERY LAW LLC
Technical classification
Nice Classes
Class 9Class 35Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Computer software that is downloaded and installed for use in connection with the accessingvisualisationanalysismanagementpublicationsharingstorage and manipulation of biological and biomedical data and images in the field of healthcarelife science and biomedical science; computer software downloadable from the Internet for use in connection with the accessingvisualisationanalysismanagementpublicationsharingstorage and manipulation of biological and biomedical data and images in the field of healthcarelife science and biomedical science;data access and data management software tools that are downloaded and installed for use in connection with the accessingvisualisationanalysismanagementpublicationsharingstorage and manipulation of biological and biomedical data and images in the field of healthcarelife science and biomedical science; downloadable electronic publications in the nature of scientific journalsperiodicals and newsletters relating to the accessingvisualisationanalysismanagementpublicationsharingstorage and manipulation of biological and biomedical data and images in the field of healthcarelife science and biomedical science; none of the foregoing for use by clinical care providersfuture or current patientstheir families in connection with pharmaceuticalsbiopharmaceuticals or therapeutic methodsproduceddesignedmarketed for providing medical and scientific research summariesreportsopinions regarding the efficacysafetypharmacological characteristicsother properties of pharmaceutical and biopharmaceutical productsproduct candidatesdevelopment programstherapeutic methodsdrug delivery systemsmedical treatmentsdiagnostic methodsrelating to a specific diseasedisordercategory thereof
Class 35
Business services relating to the accessingvisualisationanalysismanagementpublicationsharingstorage and manipulation of biological and biomedical data and images in the field of healthcarelife science and biomedical sciencemanagement of biological and biomedical data and images for business enterprises; data processing services relating to the accessingvisualisationanalysismanagementpublicationsharingstorage and manipulation of biological and biomedical data and images in the field of healthcarelife science and biomedical science; informationadvisory and consultancy services in connection with the aforesaid services; none of the foregoing for use by clinical care providersfuture or current patientstheir families in connection with pharmaceuticalsbiopharmaceuticals or therapeutic methodsproduceddesignedmarketed for providing medical and scientific research summariesreportsopinions regarding the efficacysafetypharmacological characteristicsother properties of pharmaceutical and biopharmaceutical productsproduct candidatesdevelopment programstherapeutic methodsdrug delivery systemsmedical treatmentsdiagnostic methodsrelating to a specific diseasedisordercategory thereof
Class 42
Design and development of computer softwaredata access and data management software tools for use in connection with the accessingvisualisationanalysismanagementpublicationsharingstorage and manipulation of biological and biomedical data and images in the field of healthcarelife science and biomedical science; computer programming; installationmaintenance and repair of computer software; design of computer websites and maintenance thereofall relating to the accessingvisualisationanalysismanagementpublicationsharingstorage and manipulation of biological and biomedical data and images in the field of healthcarelife science and biomedical science; software as a service (SAAS) featuring software for accessingvisualisationanalysismanagementpublicationsharingstorage and manipulation of biological and biomedical data and images in the field of healthcarelife science and biomedical science; informationadvisory and consultancy services in connection with the aforesaid services; none of the foregoing for use by clinical care providersfuture or current patientstheir families in connection with pharmaceuticalsbiopharmaceuticals or therapeutic methodsproduceddesignedmarketed for providing medical and scientific research summariesreportsopinions regarding the efficacysafetypharmacological characteristicsother properties of pharmaceutical and biopharmaceutical productsproduct candidatesdevelopment programstherapeutic methodsdrug delivery systemsmedical treatmentsdiagnostic methodsrelating to a specific diseasedisordercategory thereof
Class 45
Licensing of computer software for use in connection with the accessingvisualisationanalysismanagementpublicationsharingstorage and manipulation of biological and biomedical data and images in the field of healthcarelife science and biomedical science; informationadvisory and consultancy services in connection with the aforesaid services; none of the foregoing for use by clinical care providersfuture or current patientstheir families in connection with pharmaceuticalsbiopharmaceuticals or therapeutic methodsproduceddesignedmarketed for providing medical and scientific research summariesreportsopinions regarding the efficacysafetypharmacological characteristicsother properties of pharmaceutical and biopharmaceutical productsproduct candidatesdevelopment programstherapeutic methodsdrug delivery systemsmedical treatmentsdiagnostic methodsrelating to a specific diseasedisordercategory thereof
Publications
History of USPTO decisions and trademark events.
48 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/18/2025
FIMP
FINAL DISPOSITION PROCESSED
04/18/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/10/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/10/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
09/10/2024
TMBN
TTAB RELEASE CASE TO TRADEMARKS
08/02/2024
OP.T
OPPOSITION TERMINATED NO. 999999
08/02/2024
OP.D
OPPOSITION DISMISSED NO. 999999
08/02/2024
RFNT
REFUSAL PROCESSED BY IB
05/30/2023
OP.I
OPPOSITION INSTITUTED NO. 999999
05/03/2023
OPNS
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
05/01/2023
OPNC
OPPOSITION NOTICE (IB REFUSAL) CREATED
04/29/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/03/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/14/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/14/2022
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
11/14/2022
GPNX
NOTIFICATION PROCESSED BY IB
11/01/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/01/2022
PUBO
PUBLISHED FOR OPPOSITION
11/01/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/12/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/12/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/12/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/23/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/23/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/23/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/22/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/11/2022
GNFR
FINAL REFUSAL E-MAILED
05/11/2022
CNFR
FINAL REFUSAL WRITTEN
05/11/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/09/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/08/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/08/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/05/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/05/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/05/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/05/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/05/2022
RFNT
REFUSAL PROCESSED BY IB
11/29/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/09/2021
RFRR
REFUSAL PROCESSED BY MPU
11/08/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/08/2021
CNRT
NON-FINAL ACTION WRITTEN
10/07/2021
DOCK
ASSIGNED TO EXAMINER
10/04/2021
MAFR
APPLICATION FILING RECEIPT MAILED
07/30/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/26/2021
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
07/19/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/08/2021
Continuous trademark protection
Get notified about every new filing that threatens OMERO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.